41 related articles for article (PubMed ID: 10584541)
21. Pulmonary hypertension and hepatitis C virus related cirrhosis.
Perrone C; Paroli M; Morelli S
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
[No Abstract] [Full Text] [Related]
22. [The exacerbation of psoriasis during treatment with alfa interferon].
Pellicano R; Puiatti P; Palmas P; Rizzetto M; Ponzetto A
Recenti Prog Med; 1997 Sep; 88(9):423. PubMed ID: 9380948
[No Abstract] [Full Text] [Related]
23. [Current recommendations for the treatment of chronic hepatitis C].
Sarrazin C; Berg T; Buggisch P; Dollinger M; Hinrichsen H; Hüppe D; Manns M; Mauss S; Petersen J; Simon KG; van Thiel I; Wedemeyer H; Zeuzem S
Z Gastroenterol; 2014 Oct; 52(10):1185-97. PubMed ID: 25473687
[No Abstract] [Full Text] [Related]
24. Development of myositis after hepatitis C virus infection.
Mercado U; Avendaño-Reyes M
Clin Exp Rheumatol; 2005; 23(3):429-30. PubMed ID: 15971441
[No Abstract] [Full Text] [Related]
25. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
Wirth S; Lang T; Gehring S; Gerner P
Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
[TBL] [Abstract][Full Text] [Related]
26. Treatment of chronic hepatitis C in hemophilic patients.
Husa P; Smejkal P; Husová L; Penka M
Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
[TBL] [Abstract][Full Text] [Related]
27. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
Husa P; Smejkal P; Husová L; Chalupa P; Penka M
Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
[TBL] [Abstract][Full Text] [Related]
28. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
[No Abstract] [Full Text] [Related]
29. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Lin ZY; Hou NJ; Hsieh MY; Wang LY; Yu ML
Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178
[TBL] [Abstract][Full Text] [Related]
30. Use of growth factors with antiviral therapy for chronic hepatitis C.
Curry MP; Afdhal NH
Clin Liver Dis; 2005 Aug; 9(3):439-51, vii. PubMed ID: 16023976
[TBL] [Abstract][Full Text] [Related]
31. [An update on the treatment of chronic hepatitis C].
Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):13-5. PubMed ID: 10756878
[No Abstract] [Full Text] [Related]
32. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
